salicylaldehyde thiosemicarbazone

structure given in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Enyedy, Éva A: 1 article (10/2021)
2.	Frank, Éva: 1 article (10/2021)
3.	Keppler, Bernhard K: 1 article (10/2021)
4.	Kiss, Márton A: 1 article (10/2021)
5.	May, Nóra V: 1 article (10/2021)
6.	Petrasheuskaya, Tatsiana V: 1 article (10/2021)
7.	Wenisch, Dominik: 1 article (10/2021)
8.	Wernitznig, Debora: 1 article (10/2021)
9.	Bai, Yin-Liang: 1 article (10/2013)
10.	Cai, Xiao-Yan: 1 article (10/2013)

1.	Neoplasms (Cancer) 12/12/2022 - "A 5-bromo-substituted salicylaldehyde thiosemicarbazone (STC4) was selected for the chelator unit because of its antiproliferative activity at low micromolar levels in a panel of six cancer cell lines. " 10/01/2021 - "Anticancer Cu(II) complexes of mono- and dimethylated salicylaldehyde thiosemicarbazone-estrone hybrids possessing high solution stability and strong cytotoxic effect against 3D spheroids of a series of human cancer cells. "
2.	Hepatocellular Carcinoma (Hepatoma) 10/01/2013 - "The cytotoxicities of two oxovanadium complexes, VOI [VO(satsc)(phen)] (satsc = salicylaldehyde thiosemicarbazone, phen = 1,10-phenanthroline) and VOII [VO(3,5-dibrsatsc)(phen)](3,5-dibrsatsc = 3,5-dibromosalicylaldehyde thiosemicarbazone), were studied by performing MTT assays on human hepatoma cell lines BEL-7402, HUH-7 and HepG2. "